Related Experiment Video
Updated: May 8, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Prevalence of cardiometabolic diseases among ART-naïve people with HIV: A global systematic review and meta-analysis
Peter Vanes Ebasone1,2, Anastase Dzudie2,3,4, Nasheeta Peer1,5
1Department of Medicine, University of Cape Town, Cape Town, South Africa.
Insights
Cardiometabolic diseases (CMDs) are prevalent in people with HIV (PWH) not yet on antiretroviral therapy (ART). Early screening and targeted interventions are crucial for managing this growing health burden.
Area of Science:
- Public Health
- Infectious Diseases
- Cardiology
Background:
- Cardiometabolic diseases (CMDs) pose a significant and growing health challenge for people with HIV (PWH).
- While CMD prevalence is documented in PWH on antiretroviral therapy (ART), data for ART-naïve individuals remain limited.
- This study addresses the scarcity of comprehensive data on CMDs in ART-naïve PWH.
Purpose of the Study:
- To estimate the global prevalence of key CMDs (hypertension, diabetes, obesity, dyslipidemia) among ART-naïve PWH.
- To compare CMD prevalence in ART-naïve PWH with those on ART and HIV-negative populations.
- To identify regional variations in CMD prevalence within the ART-naïve PWH population.
Main Methods:
- A systematic review and meta-analysis of original articles published up to June 2024.
- Searched multiple databases including PubMed-MEDLINE, CINAHL, SCOPUS, and others.
- Included cross-sectional, cohort, and case-control studies with baseline CMD data for ART-naïve PWH aged 15 years and older.
- Utilized random-effects meta-analysis with double arc-sine transformation for prevalence estimation.
Main Results:
- Included 184 studies with over 424,000 participants.
- Global pooled prevalence: hypertension (14.2%), diabetes (3.6%), obesity (11.5% BMI-based, 18.3% waist circumference-based), elevated total cholesterol (14.8%), elevated LDL cholesterol (17.6%), elevated triglycerides (22.9%), and low HDL cholesterol (54.6%).
- Observed significant regional variations in the prevalence of diabetes, obesity, and dyslipidemia across UNAIDS regions.
Conclusions:
- A notable prevalence of CMDs exists among ART-naïve PWH.
- Significant regional disparities in CMD prevalence necessitate tailored public health strategies.
- Emphasizes the need for early screening, targeted interventions, and integration of CMD prevention into HIV care protocols for PWH.
Introduction:
The burden of cardiometabolic diseases (CMDs) is rising in people with HIV (PWH). While extensive data exist on CMD prevalence in PWH receiving antiretroviral therapy (ART), comprehensive data on ART-naïve PWH are scarce. We aimed to estimate the global prevalence of hypertension, diabetes, obesity and dyslipidaemia among ART-naïve PWH and compare estimates with those on ART and HIV-negative populations.
Methods:
This systematic review and meta-analysis included a search of PubMed-MEDLINE, CINAHL, SCOPUS, Academic Search Premier, Africa-Wide Information and Africa-Journals Online for original articles published up to June 2024. Cross-sectional, cohort and case-control studies providing baseline data on CMD prevalence were included. Studies had to include ART-naïve PWH aged ≥15 years. Two independent reviewers conducted studies screening, data extraction and methodological quality assessment. A random-effects meta-analysis with double arc-sine transformation was used for prevalence estimates. The study was registered with PROSPERO (CRD42021226001).
Results:
We included 184 studies published between 2000 and 2024, involving a total of 424 629 participants. The global pooled prevalence among ART-naïve PWH was 14.2% (95% CI: 12.4-16.1) for hypertension, 3.6% (2.9-4.3) for diabetes, 11.5% (10.3-12.9) for body mass index-based obesity, 18.3% (12.7-24.6) for waist circumference-based obesity, 14.8% (12.1-17.8) for elevated total cholesterol, 17.6% (11.3-24.8) for elevated low-density lipoprotein cholesterol, 22.9% (19.3-26.7) for elevated triglycerides and 54.6% (48.2-61.0) for low high-density lipoprotein cholesterol, all with high heterogeneity. Significant regional variations in the prevalence of diabetes, obesity and dyslipidaemia were observed according to UNAIDS regions.
Discussion:
We found a notable prevalence of CMDs in ART-naïve PWH, with significant regional variations in the prevalence of diabetes, obesity and dyslipidaemia. This highlights the need for targeted interventions and early screening to address the growing CMD burden among PWH.
Conclusion:
ART-naïve PWH face a considerable CMD burden, emphasizing the importance of early detection and management. Regional differences in CMD prevalence call for tailored public health strategies and integration of CMD prevention into HIV care protocols.
Related Concept Videos
Coronary Artery Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Bias in Epidemiological Studies
Coronary Artery Disease IV: Preventive Measures
Hypertension III: Clinical Manifestations and Diagnostic Studies
Retrovirus Life Cycles
